Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.

Ikoma M, Gantt S, Casper C, Ogata Y, Zhang Q, Basom R, Dyen MR, Rose TM, Barcy S.

PLoS One. 2018 Feb 9;13(2):e0192659. doi: 10.1371/journal.pone.0192659. eCollection 2018.

2.

Atypical Kaposi's sarcoma in young inmunocompetent patient.

Sánchez-López J, Pérez-Parra S, Porriño-Bustamante ML, Aneiros-Fernández J, Naranjo-Sintes R, Fernández-Pugnaire MA.

An Bras Dermatol. 2017;92(5 Suppl 1):24-26. doi: 10.1590/abd1806-4841.20175564.

3.

Prospective study of human herpesvirus 8 oral shedding, viremia, and serological status among human immunodeficiency virus seropositive and seronegative individuals in Sao Paulo, Brazil.

Braz-Silva PH, Tozetto-Mendoza TR, Sumita LM, Freire W, Palmieri M, do Canto AM, Avelino-Silva VI, Gallottini M, Mayaud P, Pannuti CS.

J Oral Microbiol. 2017 Oct 15;9(1):1384287. doi: 10.1080/20002297.2017.1384287. eCollection 2017.

4.

Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.

Li Y, Zhong C, Liu D, Yu W, Chen W, Wang Y, Shi S, Yuan Y.

Cancer Res. 2018 Jan 1;78(1):230-245. doi: 10.1158/0008-5472.CAN-17-1961. Epub 2017 Oct 24.

PMID:
29066510
5.

Oral shedding of herpesviruses in HIV-infected patients with varying degrees of immune status.

Dittmer DP, Tamburro K, Chen H, Lee A, Sanders MK, Wade TA, Napravnik S, Webster-Cyriaque J, Ghannoum M, Shiboski CH, Aberg JA.

AIDS. 2017 Sep 24;31(15):2077-2084. doi: 10.1097/QAD.0000000000001589.

PMID:
28723706
6.

Long-term nitrite inhalant exposure and cancer risk in MSM.

Dutta A, Uno H, Holman A, Lorenz DR, Wolinsky SM, Gabuzda D.

AIDS. 2017 May 15;31(8):1169-1180. doi: 10.1097/QAD.0000000000001451.

7.

KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells.

Dai L, Cao Y, Jiang W, Zabaleta J, Liu Z, Qiao J, Qin Z.

Oncotarget. 2017 May 30;8(22):35792-35803. doi: 10.18632/oncotarget.16207.

9.

Hepatic Kaposi sarcoma: A case report and review of the literature.

Van Leer-Greenberg B, Kole A, Chawla S.

World J Hepatol. 2017 Feb 8;9(4):171-179. doi: 10.4254/wjh.v9.i4.171. Review.

10.

Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus.

Dai L, Bai L, Lin Z, Qiao J, Yang L, Flemington EK, Zabaleta J, Qin Z.

Oncotarget. 2016 Jul 26;7(30):47052-47060. doi: 10.18632/oncotarget.9720.

11.

Cancer prevention in HIV-infected populations.

Goncalves PH, Montezuma-Rusca JM, Yarchoan R, Uldrick TS.

Semin Oncol. 2016 Feb;43(1):173-188. doi: 10.1053/j.seminoncol.2015.09.011. Epub 2015 Sep 8. Review.

12.

Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons.

Bender Ignacio RA, Goldman JD, Magaret AS, Selke S, Huang ML, Gantt S, Johnston C, Phipps WT, Schiffer JT, Zuckerman RA, McClelland RS, Celum C, Corey L, Wald A, Casper C.

Infect Agent Cancer. 2016 Feb 10;11:7. doi: 10.1186/s13027-016-0052-2. eCollection 2016.

13.

A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned.

Collier AC, Chun TW, Maenza J, Coombs RW, Tapia K, Chang M, Stevens CE, Justement JS, Murray D, Stekler JD, Mullins JI, Holte SE.

Biores Open Access. 2016 Jan 1;5(1):15-21. doi: 10.1089/biores.2015.0038. eCollection 2016.

14.

HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis.

Rohner E, Wyss N, Heg Z, Faralli Z, Mbulaiteye SM, Novak U, Zwahlen M, Egger M, Bohlius J.

Int J Cancer. 2016 Jan 1;138(1):45-54. doi: 10.1002/ijc.29687. Epub 2015 Jul 28. Review.

15.

Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva.

Shafiee H, Kanakasabapathy MK, Juillard F, Keser M, Sadasivam M, Yuksekkaya M, Hanhauser E, Henrich TJ, Kuritzkes DR, Kaye KM, Demirci U.

Sci Rep. 2015 Jun 5;5:9919. doi: 10.1038/srep09919.

16.

Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Sutcliffe S, Till C, Jenkins FJ, Gaydos CA, Goodman PJ, Hoque AM, Hsing AW, Thompson IM, Nelson WG, De Marzo AM, Platz EA.

Cancer Causes Control. 2015 Jan;26(1):35-44. doi: 10.1007/s10552-014-0480-5. Epub 2014 Oct 31.

17.

Utilising proteomic approaches to understand oncogenic human herpesviruses (Review).

Owen CB, Hughes DJ, Baquero-Perez B, Berndt A, Schumann S, Jackson BR, Whitehouse A.

Mol Clin Oncol. 2014 Nov;2(6):891-903. Epub 2014 Jul 9.

18.

Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.

Gong D, Wu NC, Xie Y, Feng J, Tong L, Brulois KF, Luan H, Du Y, Jung JU, Wang CY, Kang MK, Park NH, Sun R, Wu TT.

J Virol. 2014 Oct;88(19):11369-82. doi: 10.1128/JVI.00793-14. Epub 2014 Jul 23.

19.

Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells.

Dai L, DeFee MR, Cao Y, Wen J, Wen X, Noverr MC, Qin Z.

PLoS One. 2014 Jun 27;9(6):e101326. doi: 10.1371/journal.pone.0101326. eCollection 2014.

20.

Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.

Betsem E, Cassar O, Afonso PV, Fontanet A, Froment A, Gessain A.

PLoS Negl Trop Dis. 2014 May 15;8(5):e2851. doi: 10.1371/journal.pntd.0002851. eCollection 2014 May.

Supplemental Content

Support Center